New drug YK012 shows promise in early trial for blood cancer

NCT ID NCT06580301

First seen Feb 06, 2026 · Last updated May 09, 2026 · Updated 15 times

Summary

This study tests a new drug, YK012, in people with B-cell acute lymphoblastic leukemia (B-ALL), a type of blood cancer. The goal is to check if the drug is safe and to see how well it works against the cancer. About 46 participants will take part in this early-phase trial.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Affiliated Zhongshan Hospital of Dalian University

    RECRUITING

    Dalian, Liaoning, 116001, China

    Contact

    Contact

  • Guangdong Provincial People's Hospital

    RECRUITING

    Guangzhou, Guangdong, 510080, China

    Contact

  • Henan Provincial People's Hospital

    RECRUITING

    Zhengzhou, Henan, 450003, China

    Contact

  • Shengjing Hospital of China Medical University

    RECRUITING

    Shenyang, Liaoning, 110000, China

    Contact

  • Sun Yat-sen Memorial Hospital

    RECRUITING

    Guangzhou, Guangdong, 510000, China

    Contact

  • Sun Yat-sen University Cancer Center

    RECRUITING

    Guangzhou, Guangdong, 510000, China

    Contact

  • The Affiliated Hospital of Guizhou Medical University

    RECRUITING

    Guiyang, Guizhou, 550004, China

    Contact

  • The Affiliated Hospital of Xuzhou Medical University

    RECRUITING

    Xuzhou, Jiangsu, 221000, China

    Contact

  • The First Affiliated Hospital of Nanchang University

    RECRUITING

    Nanchang, Jiangxi, 330006, China

    Contact

  • The First Affiliated Hospital, Zhejiang University School of Medicine

    RECRUITING

    Hangzhou, Zhejiang, 310003, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The First Hospital of Jilin University

    RECRUITING

    Changchun, Jilin, 130021, China

    Contact

  • The Second Affiliated Hospital of Kunming Medical University

    RECRUITING

    Kunming, Yunnan, 650033, China

    Contact

Conditions

Explore the condition pages connected to this study.